Jacobs Levy Equity Management
ISEE

Jacobs Levy Equity Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Jacobs Levy Equity Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-104,126
Closed -$587K – 1113
2020
Q3 		$587K Sell
104,126
-32,956
-24% -$157K 0.01% 757
2020
Q2 		$699K Hold
137,082
– – 0.01% 731
2020
Q1 		$472K Sell
137,082
-1,201
-0.9% -$7.02K 0.01% 766
2019
Q4 		$1.19M Sell
138,283
-25,199
-15% -$90K 0.01% 655
2019
Q3 		$183K Sell
163,482
-84,779
-34% -$98.6K ﹤0.01% 855
2019
Q2 		$323K Sell
248,261
-69,686
-22% -$95.6K ﹤0.01% 805
2019
Q1 		$448K Buy
317,947
+80,400
+34% +$112K 0.01% 787
2018
Q4 		$285K Sell
237,547
-1,200
-0.5% -$2.33K 0.01% 817
2018
Q3 		$563K Buy
238,747
+11,621
+5% +$29K 0.01% 755
2018
Q2 		$620K Sell
227,126
-192,718
-46% -$532K 0.01% 758
2018
Q1 		$1.15M Sell
419,844
-51,932
-11% -$151K 0.02% 604
2017
Q4 		$1.47M Buy
471,776
+295,700
+168% +$831K 0.03% 530
2017
Q3 		$497K Buy
+176,076
New +$475K 0.01% 706
2017
Q1 		– Sell
-26,310
Closed -$127K – 1029
2016
Q4 		$127K Buy
+26,310
New +$781K ﹤0.01% 874
2016
Q2 		– Sell
-5,040
Closed -$213K – 1253
2016
Q1 		$213K Sell
5,040
-22,110
-81% -$1.13M ﹤0.01% 955
2015
Q4 		$2.13M Sell
27,150
-10,460
-28% -$605K 0.04% 333
2015
Q3 		$1.52M Buy
37,610
+16,930
+82% +$897K 0.03% 412
2015
Q2 		$1.08M Buy
20,680
+6,840
+49% +$340K 0.02% 457
2015
Q1 		$644K Sell
13,840
-1,740
-11% -$90.3K 0.01% 554
2014
Q4 		$699K Buy
+15,580
New +$654K 0.01% 560

Other funds holding ISEE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Jacobs Levy Equity Management's ISEE Position: Q4 2020 in Review

Jacobs Levy Equity Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2020, closing a stake of 104,126 shares — an estimated $587K sold.

Jacobs Levy Equity Management first reported a position in ISEE in Q4 2014 and held it in 20 quarters. The position peaked at $2.13M in Q4 2015. 120 funds tracked by Wall St. Rank hold ISEE as of Q4 2020.

  • Jacobs Levy Equity Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 104,126 IVERIC bio, Inc. Common Stock shares in Q4 2020, an estimated $587K.
  • Jacobs Levy Equity Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2014 and held it in 20 quarters.
  • Jacobs Levy Equity Management's IVERIC bio, Inc. Common Stock position peaked at $2.13M in Q4 2015.
  • 120 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2020.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2020, filed 16 Feb 2021.